Edwards Lifesciences Corp. a leader in advanced cardiovascular disease treatments, is the number-one heart valve company in the world and the global leader in acute hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards focuses on specific cardiovascular disease states including heart valve disease, peripheral vascular disease and critical care technologies. The company's global brands, which are sold in approximately hundred countries, include Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, LifeStent, PERIMOUNT Magna and Swan-Ganz. Edwards Lifesciences, Carpentier-Edwards, Cosgrove-Edwards, Fogarty, PERIMOUNT Magna and Swan-Ganz are trademarks of Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark Office. LifeStent is a trademark of Edwards Lifesciences AG and is registered in the United States Patent and Trademark Office. Edwards Lifesciences Corp. has a market cap of $4.54 billion; its shares were traded at around $80.49 with a P/E ratio of 26.9 and P/S ratio of 3.7. Edwards Lifesciences Corp. had an annual average earning growth of 6.9% over the past 5 years.
EW is in the portfolios of Ron Baron of Baron Funds, Richard Aster Jr of Meridian Fund, Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC, Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC, PRIMECAP Management.
Insiders' Positions with EW
- Sell:: Chairman & CEO Michael A Mussallem sold 40,000 shares of EW stock on 10/13/2009 at the average price of 70.03, the price of the stock has increased by 14.94% since
- Sell:: Chairman & CEO Michael A Mussallem sold 10,328 shares of EW stock on 09/15/2009 at the average price of 66.18, the price of the stock has increased by 21.62% since
- Sell:: Chairman & CEO Michael A Mussallem sold 29,672 shares of EW stock on 09/14/2009 at the average price of 66.66, the price of the stock has increased by 20.75% since
- Sell:: Chairman & CEO Michael A Mussallem sold 40,000 shares of EW stock on 08/13/2009 at the average price of 64.38, the price of the stock has increased by 25.02% since
- Sell:: Chairman & CEO Michael A Mussallem sold 40,198 shares of EW stock on 07/09/2009 at the average price of 65.14, the price of the stock has increased by 23.56% since
Insiders' Positions with EW
- Sell:: CVP & Pres., Global Ops Corinne H Lyle sold 10,000 shares of EW stock on 11/09/2009 at the average price of 80.05, the price of the stock has increased by 0.55% since
- Sell:: CVP & Pres., Global Ops Corinne H Lyle sold 10,000 shares of EW stock on 10/27/2009 at the average price of 76.93, the price of the stock has increased by 4.63% since
- Sell:: CVP, Europe Patrick B Verguet sold 13,500 shares of EW stock on 10/27/2009 at the average price of 76.53, the price of the stock has increased by 5.17% since
- Sell:: CVP, Critical Care & Vascular Carlyn D Solomon sold 12,500 shares of EW stock on 10/26/2009 at the average price of 76.5, the price of the stock has increased by 5.22% since
- Sell:: CVP, THV Replacement Larry L Wood sold 10,000 shares of EW stock on 10/26/2009 at the average price of 76.14, the price of the stock has increased by 5.71% since
Become a Premium Member to See This: (Free Trial):
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys:: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.
Rate This Article: |
  |